# Fsh 450Iu-Lh 225Iu

## Pergoveris 450 IU + 225 IU

| 藥物代碼 | IPER4 |
| :--- | :--- |
| 適應症 | Infertility in male & female. |
| 副作用 | Ovarian hyperstimulation, ascites, hydrothorax, oliguria, hypotension, thromboembolism, hypersensitivity reactions, fever, nausea & vomiting, inj site reactions, unintentional multiple pregnancies. |
| 禁忌 | Pregnancy & lactation; enlargement of the ovaries or cysts not due to polycystic ovarian syndrome; gynaecological bleeding of unknown origin; tumors in the uterus, ovaries & breasts. |
| 藥物保存方式 | 冷藏2-8oC,不可冷凍. |
| 用法用量 | y IM or SC inj. Female Initially 75-150 iu of FSH daily & gradually adjusted if necessary until an adequate response is achieved. To induce ovulation, 5000-10,000 iu HCG should be administered by IM inj after the last dose of HMG. A 2nd HCG administration of 5000 iu may be given 7 days afterwards to improve luteal function. Male 1 vial of Pergoveris administered 3 times/week, along with 3000 iu of HCG/week. This dosage should be maintained for 10-12 wks, or until there is evidence of improvement in spermatogenesis. |
| 肝功能異常 | 無需調整劑量  需調整劑量 |
| 腎功能異常 | 無需調整劑量  需調整劑量 |
| 懷孕用藥危分級 | 不可使用 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | SC |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

